Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 03 Mar 2026 for Organogenesis Holdings Inc.. Read the official filing
Filing timeline
BuySaleGary S. Gillheeney
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Gary S. Gillheeney: trading record in brief
Gary S. Gillheeney (chief executive) discloses dealings in Organogenesis Holdings Inc. to SEC (Form 4). Over a trading history stretching from 16 July 2021 to 18 February 2026, the count stands at 23 filings.
Sales make up the whole of the open-market record (2 sales, €380k). The rest of the record consists of 13 share grants and 8 option exercises.
The newest entry dates from 3 March 2026: a share grant, in Organogenesis Holdings Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gary S. Gillheeney
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
188,856 shares0Class A Common StockSEC:0002064832-26-000091:0
890,625 shares0Class A Common StockSEC:0002064832-26-000057:0
24,340 shares@ US$3.732.6% of flowClass A Common StockSEC:0002064832-26-000027:0
708,215 shares0Class A Common StockSEC:0001062993-25-003212:0
82,814 shares@ US$3.7010.3% of flowClass A Common StockSEC:0001062993-25-002937:0
55,615 shares@ US$3.366.3% of flowClass A Common StockSEC:0001062993-24-020701:0
58,525 shares@ US$3.647.1% of flowClass A Common StockSEC:0001062993-24-020566:0
1,067,245 shares@ US$0.9935.4% of flowClass A Common StockSEC:0001062993-24-020285:0
10,113 shares@ US$2.800.9% of flowClass A Common StockSEC:0001062993-24-007931:0
685,131 shares0Class A Common StockSEC:0001062993-24-004310:0
65,774 shares@ US$3.688.0% of flowClass A Common StockSEC:0001062993-24-003764:0
6,470 shares@ US$2.130.4% of flowClass A Common StockSEC:0001062993-23-008507:0
896,414 shares0Class A Common StockSEC:0001062993-23-004887:0
21,517 shares@ US$2.922.1% of flowClass A Common StockSEC:0001062993-23-004054:0
505,050 shares@ US$0.990.073% mcap57.2% of flowClass A Common StockSEC:0001062993-22-015767:0
94,487 shares@ US$0.993.0% of flowClass A Common StockSEC:0001062993-22-014294:0
61,202 shares@ US$0.992.0% of flowClass A Common StockSEC:0001062993-22-013879:0
6,670 shares@ US$0.990.2% of flowClass A Common StockSEC:0001062993-22-013521:0
86,531 shares@ US$0.992.8% of flowClass A Common StockSEC:0001062993-22-013178:0
14,810 shares@ US$0.990.5% of flowClass A Common StockSEC:0001062993-22-012849:0
9,789 shares@ US$7.892.4% of flowClass A Common StockSEC:0001062993-22-009815:0
280,199 shares0Class A Common StockSEC:0001062993-22-004794:0
24,313 shares@ US$0.990.7% of flowClass A Common StockSEC:0001661181-21-000062:0
23 of 23 declarations
